Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 8.0B | 7.7B | 7.8B | 6.9B |
Cost of revenue | 6.7B | 1.6B | 1.6B | 2.6B |
Gross profit | 1.3B | 6.1B | 6.2B | 4.3B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 3.0B | 3.0B | 2.8B | 2.5B |
Operating income | 1.5B | 1.4B | 1.8B | 1.4B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 268M | 257M | 199M | 179M |
Other income expense | — | — | — | — |
Pretax income | 1.3B | 1.3B | 1.6B | 1.3B |
Tax provision | 280M | 421M | 415M | 319M |
Net income | 1.1B | 925M | 1.2B | 952M |
Basic EPS | — | 2.2 | 2.7 | 2.2 |
Diluted EPS | — | 2.2 | 2.7 | 2.2 |
Basic average shares | — | 399.5M | 400.7M | 400.2M |
Diluted average shares | — | 399.5M | 400.7M | 400.2M |
EBITDA | 2.1B | 2.1B | 2.2B | 1.8B |
Net income from continuing op. | — | — | — | — |
Minority interests | -43M | -38M | -133M | -86M |
Preferred stock dividends | 0 | 0 | 0 | 0 |